Stock comparison
Side-by-side financials for BDMD and DXCM. Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
DXCM is larger
Market cap data is available for the leading company in this comparison.
Market value leader
DXCM
Latest market capitalization comparison.
Revenue leader
DXCM
BDMD: $22.54M vs DXCM: $4.66B.
Profit leader
DXCM
BDMD: -$27.28M vs DXCM: $836.30M.
Margin leader
DXCM
BDMD: -121.0% vs DXCM: 17.9% net margin.
| Metric | BDMD | DXCM |
|---|---|---|
| Market cap | - | $33.92 B |
| US-listed rank | - | #438 |
| Revenue (latest FY) | $22.54M | $4.66B |
| Net income (latest FY) | -$27.28M | $836.30M |
| Net margin | -121.0% | 17.9% |
| P/E (trailing FY) | - | 40.6x |
| SEC filings | 68 | 2,566 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
In their latest fiscal years, Baird Medical Investment Holdings Ltd reported $22.54M in revenue while DEXCOM INC reported $4.66B.
Full pages: Baird Medical Investment Holdings Ltd and DEXCOM INC, or browse the full rankings.